review Open AccessTop 1% cited
Phases of Biomarker Development for Early Detection of Cancer
JNCI Journal of the National Cancer Institute · 2001 · Vol. 93(14) · pp. 1054–1061
M. S. Pepe✉(University of Washington)Ruth Etzioni(Fred Hutch Cancer Center)Zhu Feng(Fred Hutch Cancer Center)John D. Potter(Fred Hutch Cancer Center)Mary Lou Thompson(University of Washington)Mark Thornquist(Fred Hutch Cancer Center)Marcy Winget(Fred Hutch Cancer Center)Yutaka Yasui(Fred Hutch Cancer Center)
Cancer Genomics and DiagnosticsStatistical Methods in Clinical TrialsMolecular Biology Techniques and ApplicationsBiomarkerCancerMedicineBiologyOncologyInternal medicineGenetics
MeSH terms
AnimalsClinical Trials as TopicHumansMass ScreeningNeoplasmsProspective StudiesRetrospective StudiesBiomarkers, TumorOutcome Assessment, Health CareSample Size
Citations
1,628
FWCI
11.41
field-weighted impact
References
30
Percentile
99%
vs. same field & year
Citations per year
Cited by
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Cells · 2020 · 489 citations
Interleukin 6 and Interleukin 8 as Potential Biomarkers for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma
Archives of Otolaryngology - Head and Neck Surgery · 2004 · 426 citations
Methods of in vitro toxicology
Food and Chemical Toxicology · 2002 · 450 citations
Biomarkers for the early diagnosis of hepatocellular carcinoma
World Journal of Gastroenterology · 2015 · 579 citations
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Urology · 2005 · 427 citations
References
Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry
Electrophoresis · 2000 · 687 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.